血管炎性肌病:临床特征与长期结局
该回顾性病历综述纳入1980至2022年诊断为血管炎合并肌病的25例患者,其中80%以肌病为首发表现,多数为近端对称性无力,CK多正常而醛缩酶多升高,肌活检见血管周围炎、血管壁炎症破坏及纤维素样坏死,24例经免疫治疗改善,仅3例复发,1年与5年生存概率分别为96%与84%。
要点
- 血管炎性肌病可为系统性血管炎的首发表现,也可为非系统性形式。
- 多数患者近端对称性无力,CK多正常而醛缩酶升高,肌电图示近端及轴向肌肉短时限运动单位电位。
- 多数患者对免疫治疗反应良好,复发少见。
核心结论
- 肌病可以是原发性或继发性系统性血管炎的首发表现,也可表现为非系统性形式;多数患者以近端为主的无力和正常CK、升高醛缩酶为特点,通常对免疫治疗反应良好。
研究设计与样本
- 回顾性病历综述,纳入1980至2022年诊断为血管炎合并肌病的患者,共25例。
- 纳入标准为活检证实的血管炎性肌病,或非肌肉组织活检证实的血管炎合并活动性肌病且排除其他原因。
- 所有肌肉活检切片均重新审阅,并补充免疫组化检查。
主要发现
- 25例患者中女性占60%,诊断时中位年龄63岁(四分位距38-81岁)。
- 10例(40%)为原发性系统性血管炎,12例(48%)为继发性系统性血管炎,3例(12%)为非系统性血管炎性肌病。
- 肌病为血管炎初始表现者20/25例(80%);19例(76%)起病时有疼痛,其中2例仅神经病理性疼痛、10例仅肌痛、7例远端神经病理性疼痛合并近端肌痛。
- CK升高3/23例(13%),醛缩酶升高10/16例(63%);肌电图示近端及轴向肌肉短时限运动单位电位23/24例(96%),合并周围神经病15/24例(63%)。
- 肌活检均见血管周围炎症,血管壁炎症和破坏18/21例(86%),纤维素样坏死13/21例(62%);所有标本非坏死纤维均见主要组织相容性复合体I类肌膜反应性增高;多数浸润以CD4+ T细胞为主,部分见血管补体沉积。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Peripheral neuropathy is a common manifestation of systemic and nonsystemic vasculitides; however, there is limited literature on vasculitic myopathy. We aim to describe the clinical, laboratory, and pathologic characteristics and treatment outcomes of vasculitic myopathy. METHODS: A retrospective chart review of patients with a diagnosis of vasculitis and myopathy (1980-2022) was performed. Patients were included with either biopsy-proven vasculitic myopathy or biopsy-proven vasculitis (of nonmuscle tissue) and concomitant active myopathy after excluding alternative causes. All muscle biopsy slides were reviewed, and additional immunohistochemistry studies were performed. RESULTS: Twenty-five patients with vasculitic myopathy were identified, 60% were female, and the median age at diagnosis was 63 (interquartile range 38-81) years. Ten patients (40%) had a primary systemic vasculitis, 12 secondary systemic vasculitis (48%), and 3 had nonsystemic vasculitic myopathy (12%). Myopathy was the initial manifestation of vasculitis in 20 of 25 patients (80%). Weakness was proximal and symmetric in most cases. Nineteen patients (76%) had pain at presentation: 2 with only neuropathic pain, 10 with only myalgia, and 7 had a combination of neuropathic pain distally and myalgia proximally. Creatine kinase (CK) was elevated in 3 of 23 patients (13%) and aldolase elevated in 10 of 16 patients (63%). Electromyography revealed short duration motor unit potentials in proximal and axial muscles in 23 of 24 patients (96%) and superimposed peripheral neuropathy in 15 of 24 (63%). Muscle biopsy showed perivascular inflammation in all biopsies, vessel wall inflammation and destruction in 18 of 21 (86%), and fibrinoid necrosis in 13 of 21 biopsies (62%). Masson trichrome stain facilitated the detection of fibrinoid necrosis. All muscle specimens had increased major histocompatibility complex class I sarcolemmal reactivity in nonnecrotic fibers. In most patients, the inflammatory infiltrates were predominantly CD4+ T cells, with complement deposition on blood vessels in some. Twenty-four patients improved with immunotherapy, and only 3 patients relapsed. Seven patients died during the study period, 1 from vasculitis complications. Probability of survival at 1 and 5 years was 96% and 84%, respectively. DISCUSSION: Myopathy can be the initial manifestation of a primary or secondary systemic vasculitis or may occur as a nonsystemic form. Most patients present with proximal predominant weakness with normal CK and elevated aldolase levels. Patients usually respond well to immunotherapy.
引用
- Pinto MV, Warrington KJ, Soontrapa P, et al. Vasculitic Myopathy: Clinical Characteristics and Long-Term Outcomes. Neurology. 2024. PMID: 39586051. doi:10.1212/WNL.0000000000210141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。